Respiratory Diseases

 
Passive Smoke Exposure in Childhood May Cause Subclinical LV Dysfunction in Adults
November 11, 2020

AHA 2020 Virtual Scientific Sessions: Cumulative exposure, exposure intensity, and number of household smokers in childhood all impact adult heart function, study authors found.

Tezepelumab for Severe Asthma Meets Phase 3 Primary Endpoint
November 10, 2020

The novel monoclonal antibody could bring relief to millions of persons with severe, uncontrolled asthma, including those with a low eosinophil phenotype.

COPD Self-management App Reduces Exacerbations, Readmissions vs Usual Care
November 06, 2020

Use of the myCOPD app after hospitalization for acute COPD exacerbation reduced subsequent exacerbations by nearly 50%, according to study authors.

COPD Diagnosis in Primary Care: 6 Essential Facts
November 03, 2020

Most diagnoses of COPD are made in the primary care setting. Try these 6 questions to see what you know about the essentials of the differential diagnosis.

CVD Mortality in COPD Related to Factors Other than Lung Function Decline
October 05, 2020

In COPD patients, a new study found no association between lung function decline and individual CVD outcomes, but disease exacerbations and dyspnea were implicated.

Genetic Mutations May Underlie Severe COVID-19 Illness
September 25, 2020

More than 10% of those who develop severe COVID-19 have misguided antibodies that derail the immune response, according to new research.

Asthma: Long-acting Muscarinic Antagonists Overused, Up Exacerbation Risk
September 17, 2020

Long-acting muscarinic antagonists, recommended as add-on therapy for asthma, are too often used as monotherapy and are linked with severe exacerbations, a new study finds.

“Social Smoking” Linked to Disproportionately High Risk of Death from Lung Disease, Lung Cancer
September 08, 2020

New research presented at the virtual European Respiratory Society International Congress showed "social smokers" are more than twice as likely to die of lung disease vs non-smokers.

NIH COVID-19 Treatment Guidelines Updated Based on New Data
August 27, 2020

Treatment guidelines on COVID-19 from the NIH were updated today based on data from clinical trials of hydroxychloroquine, ivermectin, and IL-6 inhibitors.

ACIP Revises Adult Pneumococcal Vaccination Recommendations: Good, Bad, and Ugly
August 18, 2020

The ACIP, once more, revised its recommendations for administration of pneumococcal vaccination among adults aged ≥65 years. Is there a lesson learned here?